1st Global Advisors’s Bristol-Myers Squibb BMY Stock Holding History

1st Global Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$3.35M	Buy	+60,139	New	+$3.27M	0.39%	34

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

1st Global Advisors's BMY Position: Q2 2017 in Review

1st Global Advisors opened a new position in Bristol-Myers Squibb (BMY) in Q2 2017: 60,139 shares worth $3.35M. The stake represents 0.39% of the portfolio and ranks #34 among its holdings.

1,594 funds tracked by Wall St. Rank hold BMY as of Q2 2017.

1st Global Advisors held 60,139 shares of Bristol-Myers Squibb worth $3.35M as of Q2 2017.
Bristol-Myers Squibb was a new 1st Global Advisors position in Q2 2017.
Bristol-Myers Squibb made up 0.39% of 1st Global Advisors's portfolio in Q2 2017, its #34 holding.
1,594 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2017.

Based on 1st Global Advisors's 13F filing for Q2 2017, filed 15 Aug 2017.